Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Stage

Series B

Employees

51-200

Links

Org chart

Torben Straight Nissen

CEO

Collapse

Thomas L. Andresen

Co-founder

Ewen Cameron

Co-Founder

Jan Kisielow

Chief Scientific Officer, Repertoire Immune Medicines (Switzerland) Ltd.

John Delyani

Chief Business Officer

Cara Lowen

VP & Chief Intellectual Property Counsel

Ellen Forest

SVP & Head of Human Capital

Andy Hurwitz

SVP & Head of Immunology

Arthur Hurwitz

Senior Vice President

Jonathan Fitzgerald

VP, Program Management

Suzanne Greco

VP, Finance

Franz-Josef Obermair

General Manager, Tepthera Subsidiary

Teams

View all

Board of Directors

9 members

Leadership Team

5 members

CEO and Executive Team

2 members

Discover similar companies

Allakos

San Carlos, United States · Post IPO Equity

TwinStrand Biosciences

Seattle, United States · Series B

Erasca

San Diego, United States · Post IPO Equity

Korro Bio

Cambridge, United States · Series B

Sonoma Biotherapeutics

South San Francisco, United States · Corporate Round

ShapeTX

Seattle, United States · Series B

Verve Therapeutics

Cambridge, United States · IPO

Sherlock Biosciences

Boston, United States · Grant

Entrada Therapeutics

Boston, United States · Post IPO Equity

StrideBio

Durham, United States · Series B

AVROBIO

Cambridge, United States · IPO

Neon Therapeutics

Cambridge, United States · IPO

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.